Mode
Text Size
Log in / Sign up

Natural anti-inflammatory products modulate the FOXP3-C5aR1-LIF axis to potentially manage chronic rhinosinusitisNatural Compounds May Help Manage Chronic Rhinosinusitis Symptoms

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that natural products may modulate key immune pathways like JAK-STAT and Th17 polarization in rhinosinusitis.

This systematic review explores the role of natural anti-inflammatory products—specifically epigallocatechin-3-gallate, curcumin, rosmarinic acid, bromelain, and cineole—in managing chronic rhinosinusitis (CRS) and acute sinusitis. The synthesis focuses on how these compounds interact with immune signaling pathways to modulate inflammatory responses.

Key findings indicate that FOXP3+ Tregs are highly depleted in CRS with nasal polyps. The review highlights the importance of the FOXP3-C5aR1-LIF axis, noting that C5aR1 signaling prevents active Treg induction via the PI3K-AKT-mTOR pathway, while LIF enhances FOXP3 expression and opposes Th17 polarization. Natural products like epigallocatechin-3-gallate, curcumin, and rosmarinic acid are reported to regulate these pathways by inhibiting DNA methyltransferases, the complement cascade, and JAK-STAT signaling. Additionally, clinical evidence supports the efficacy of bromelain and cineole in acute sinusitis.

Limitations noted include a lack of optimized bioavailability formulations for several compounds and a need for systematic exploration of synergistic combinations. The authors also note that current biologics may overlook the FOXP3-C5aR1-LIF axis. These findings suggest that natural compounds may offer multi-target activity to modulate the upstream immune system in CRS, though specific clinical evidence is currently limited to certain compounds in acute settings.

How this fits prior evidence

This review extends prior coverage of curcumin and epigallocatechin-3-gallate by exploring their roles in modulating the FOXP3-C5aR1-LIF axis specifically for chronic rhinosinusitis. While previous evidence noted that EGCG shows potential in animal models and curcumin has therapeutic potential as a theranostics agent, this review adds specific mechanisms regarding JAK-STAT signaling and Th17 polarization. It also addresses the gap in multi-target natural interventions for CRS compared to existing clinical data for bromelain and cineole in acute sinusitis.

A systematic review looked at how certain natural compounds might affect the immune system in people with chronic rhinosinusitis (CRS). The researchers focused on substances such as epigallocatechin-3-gallate, curcumin, rosmarinic acid, bromelain, and cineole. These ingredients are often studied for their anti-inflammatory properties.

The review found that these natural products may work by targeting specific pathways in the body. For example, they might help regulate immune cells that control inflammation. Specifically, some evidence suggests that bromelain and cineole have shown clinical effectiveness in treating acute sinusitis cases.

Because this was a review of existing research, the results are not yet definitive for all types of treatment. Some compounds only have evidence for acute cases rather than long-term chronic conditions. You should talk to your doctor before starting any new supplements to ensure they are safe and appropriate for your specific health needs.

What this means for you:
Some natural compounds show potential to manage inflammation in sinusitis, but more research is needed.

Common questions

What natural ingredients were studied for sinusitis?

The review looked at several natural anti-inflammatory products, including epigallocatechin-3-gallate, curcumin, rosmarinic acid, bromelain, and cineole. These substances are being studied for their potential to modulate the immune system in people with chronic rhinosinusitis.

Are these treatments effective for all types of sinusitis?

The evidence varies by ingredient. While some compounds show promise for managing the immune pathways involved in chronic rhinosinusitis, clinical evidence specifically favoring efficacy was noted for bromelain and cineole in cases of acute sinusitis.

How do these natural products work in the body?

These compounds may work by inhibiting specific signaling pathways and processes like DNA methyltransferases and the complement cascade. This helps regulate the immune system's response to inflammation in the nasal passages.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Chronic rhinosinusitis (CRS) is a condition with a significant healthcare and economic burden, with a prevalence of 12% in the West. The existing therapies mainly attenuate downstream inflammatory mediators but do not address the underlying immune-regulatory abnormalities that drive disease recurrence and lifelong treatment. Evidence has shown that a regulatory axis involving forkhead box P3 (FOXP3) + regulatory T cells (Tregs), the complement component 5a receptor 1 (C5aR1), and leukemia inhibitory factor (LIF) is crucial for regulating immune tolerance in sinonasal tissues. This review discusses the mechanistic basis for modulating FOXP3, C5aR1, and LIF with natural anti-inflammatory products for the treatment of CRS. A comprehensive literature review across PubMed, Scopus, and Web of Science (2000–2026) was conducted to identify research articles on the molecular mechanisms, preclinical evidence, and clinical application of natural compounds in inflammatory disorders and the sinonasal inflammatory pathway. Various studies show that FOXP3+ Tregs are highly depleted in CRS with nasal polyps. Besides, complement signaling via C5aR1 prevents active Treg induction by activating the PI3K-AKT-mTOR pathway. LIF enhances the expression of FOXP3 and opposes Th17 polarization caused by IL-6. Natural products such as epigallocatechin-3-gallate, curcumin, and rosmarinic acid regulate pathways by inhibiting DNA methyltransferases, the complement cascade, and JAK-STAT signaling. Bromelain and cineole have clinical evidence in favor of efficacy in acute sinusitis, and other compounds are showing emerging evidence. The FOXP3-C5aR1-LIF axis is a mechanistic therapeutic target that is largely overlooked by the current biologics. Natural compounds offer potential benefits, including multi-target activity, favorable safety profiles, and the ability to modulate the upstream immune system. Phenotype-based CRS populations should be studied in well-designed trials, bioavailability formulations should be optimized, and synergistic combinations should be systematically explored.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.